LOOMIS SAYLES & CO L P – Alnylam Pharmaceuticals, Inc. Transaction History
LOOMIS SAYLES & CO L P portfolio value:
$149.67M
portfolio value
LOOMIS SAYLES & CO L P quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -9.70% | -80.32K shares | 28.89M | $200.16 | 747.75K |
| Q2 2022 | share | Decrease | -4.68% | -40.66K shares | -21.08M | $145.85 | 828.07K |
| Q1 2022 | share | Decrease | -12.81% | -127.68K shares | -27.11M | $163.29 | 868.74K |
| Q4 2021 | share | Increase | +2.93% | 28.33K shares | -13.81M | $171.03 | 996.43K |
| Q3 2021 | share | Increase | +2.33% | 22.04K shares | 22.41M | $188.81 | 968.10K |
| Q2 2021 | share | Increase | 0.00% | 946.06K shares | 160.37M | $169.52 | 946.06K |